Top Markets
Coin of the day
Ortin Laboratories Limited Ortin Laboratories Limited

Ortin Laboratories Limited

ORTINLAB
Rank in Stocks #37115
Ortin Laboratories Limited, a pharmaceutical company established in Hyderabad,... Ortin Laboratories Limited, a pharmaceutical company established in Hyderabad, India, in 1986, is engaged in the manufacturing and commercialization of a diverse range of medicines, drugs, and chemical intermediates. The company provides a wide array of pharmaceutical formulations, presented as tablets, capsules, syrups, and dry powders. These products target various therapeutic domains such as metabolic diseases (e.g., anti-diabetics), allergic reactions, infections (including broad-spectrum antibiotics and antifungals like quinolones, penicillins, cephalosporins, macrolides, and antifungals), pain management and fever reduction (analgesics and antipyretics), cardiovascular ailments (anti-anginal and cardiovascular products), digestive system disorders (antacids and anti-ulcerants), neurological and psychiatric conditions (sedatives, tranquilizers, psychiatry products), and nutritional supplementation (like vitamins, calcium, iron, and protein supplements). Specialized offerings also include anti-retroviral, anti-arthritic, anti-helminthic, anti-spasmodic, gynaec, appetite stimulators, and chemotherapeutic preparations. In addition to finished pharmaceuticals, Ortin produces active pharmaceutical ingredient (API) intermediates for applications such as anti-retrovirals, anti-diabetics, pain and fever medications, antibiotics, antifungals, antacids, anti-malarials, and anti-ulcerants. Its manufacturing capabilities also extend to fine chemicals and Grignard/alkali metal compounds. The company offers specialized services covering process development and characterization, analytical research, assay development, and product characterization. It also contributes to diagnostics through the development of rapid flow kits, assays, and reagents. Ortin Laboratories undertakes long-term contracts for the production of intermediates and the creation of novel APIs. Moreover, it actively functions as a merchant exporter of its finished pharmaceutical products.
Share Price
$0.2488447
Last synced: 2024-10-01
Market Cap
$2.01M
Change (1 day)
-1.88%
Change (1 year)
0.00%
Country
IN
Trade Ortin Laboratories Limited (ORTINLAB)

Category

Operating Margin for Ortin Laboratories Limited (ORTINLAB)
Operating Margin as of August 2026 TTM: -989.65%
According to Ortin Laboratories Limited latest financial reports and stock price the company's current Operating Margin (TTM) is -989.65%. At the end of 2023 the company had an Operating Margin of 4.50%.
Operating Margin history for Ortin Laboratories Limited from 2008 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) -989.65% 208.87%
2024 -320.41% -7,220.22%
2023 4.50% 15.98%
2022 3.88% -66.98%
2021 11.75% 505.67%
2020 1.94% -35.76%
2019 3.02% -36.02%
2018 4.72% 95.85%
2017 2.41% -31.34%
2016 3.51% 3.24%
2015 3.40% 14.48%
2014 2.97% -5.71%
2013 3.15% 3.62%
2012 3.04% -10.32%
2011 3.39% -18.31%
2010 4.15% 24.62%
2009 3.33% -35.09%
2008 5.13% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
0.00% -
DE
0.00% -
DE
0.00% -
JP
0.00% -
CH
22.93% -100.02%
IN
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.